REGENERON
Pharmaceutical preparations and substances for the treatment and/or prevention of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer; genetically modified cells, genome editing reagents, and biological preparations, namely, viral vectors, all for the treatment and/or prevention of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer; pharmaceutical preparatio...
Pending · May 23, 2025 · 99199652 ·